Mednax is a medical care facilities business based in the US. Mednax shares (MD) are listed on the NYSE and all prices are listed in US Dollars. Mednax employs 4,120 staff and has a trailing 12-month revenue of around $1.9 billion.
Probability of Member receiving $1,000 is a probability of 0.026%; If you don’t make a selection in 45 days, you’ll no longer qualify for the promo. Customer must fund their account with a minimum of $50.00 to qualify. Probability percentage is subject to decrease.
Terms and conditions apply*. For 401k rollovers, existing SoFi IRA members must complete 401k rollovers via this link For SoFi members without a SoFi IRA, a SoFi IRA must first be opened, and 401k rollover must be completed utilizing Capitalize via this link. SoFi and Capitalize will charge no additional fees to process a 401(k) rollover to a SoFi IRA. SoFi is not liable for any costs incurred from the existing 401k provider for rollover. Please check with your 401k provider for any fees or costs associated with the rollover. For IRA contributions, only deposits made via ACH and cash transfer from SoFi Bank accounts are eligible for the match. Click here for the 1% Match terms and conditions.
Trade stocks, ETFs, options, futures and bonds all in one place
$0 commissions on stocks, ETFs and equity options, with low contract fees
Deposit or transfer $10,000+ to earn a 2% Match Bonus. Plus: Get a $100 transfer fee reimbursement on your first brokerage transfer of $2,000 or more. T&C apply.
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Mednax stock price (NYSE: MD)
Use our graph to track the performance of MD stocks over time.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Is Mednax stock undervalued or overvalued?
Valuing Mednax stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Mednax's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Mednax's P/E ratio
Mednax's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 13x. In other words, Mednax shares trade at around 13x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Mednax's PEG ratio
Mednax's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.88. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Mednax's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Mednax's EBITDA
Mednax's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $257.6 million.
The EBITDA is a measure of a Mednax's overall financial performance and is widely used to measure a its profitability.
Mednax financials
Revenue TTM
$1.9 billion
Operating margin TTM
15.02%
Gross profit TTM
$496.2 million
Return on assets TTM
6.86%
Return on equity TTM
19.98%
Profit margin
8.44%
Book value
$10.59
Market Capitalization
$2.1 billion
TTM: trailing 12 months
Mednax's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Mednax.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Mednax's total ESG risk score
Total ESG risk: 19.73
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Mednax's overall score of 19.73 (as at 12/31/2018) is pretty good – landing it in it in the 22nd percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Mednax is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Mednax's environmental score
Environmental score: 1.84/100
Mednax's environmental score of 1.84 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Mednax is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Mednax's social score
Social score: 8.57/100
Mednax's social score of 8.57 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Mednax is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Mednax's governance score
Governance score: 5.5/100
Mednax's governance score puts it squarely in the 1st percentile of companies rated in the same sector. That could suggest that Mednax is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Mednax's controversy score
Controversy score: 1/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Mednax scored a 1 out of 5 for controversy – the highest score possible, reflecting that Mednax has managed to keep its nose clean.
Environmental, social, and governance (ESG) summary
Mednax Inc was last rated for ESG on: 2019-01-01.
Total ESG score
19.73
Total ESG percentile
21.62
Environmental score
1.84
Environmental score percentile
1
Social score
8.57
Social score percentile
1
Governance score
5.5
Governance score percentile
1
Level of controversy
1
Mednax share dividends
We're not expecting Mednax to pay a dividend over the next 12 months.
Have Mednax's shares ever split?
Mednax's shares were
split on a 2:1 basis on 19 December 2013
. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Mednax shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Mednax shares which in turn could have impacted Mednax's share price.
Mednax share price volatility
Over the last 12 months, Mednax's shares have ranged in value from as little as $11.84 up to $24.99. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Mednax's is 0.809. This would suggest that Mednax's shares are less volatile than average (for this exchange).
Mednax overview
Pediatrix Medical Group, Inc. , together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal medicine nurse practitioners, certified nurse mid-wives, sonographers, and genetic counselors. In addition, it offers other pediatric subspecialty care services, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and other newborn and pediatric care, as well as newborn hearing screening, and support services in hospitals, pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc.
Frequently asked questions
What percentage of Mednax is owned by insiders or institutions? Currently 2.13% of Mednax shares are held by insiders and 98.241% by institutions.How many people work for Mednax? Latest data suggests 4,120 work at Mednax.When does the fiscal year end for Mednax? Mednax's fiscal year ends in December.Where is Mednax based? Mednax's address is: 1301 Concord Terrace, Sunrise, FL, United States, 33323What is Mednax's ISIN number? Mednax's international securities identification number is: US58502B1061What is Mednax's CUSIP number? Mednax's Committee on Uniform Securities Identification Procedures number is: 705324101
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
Advertiser disclosure
Finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which Finder receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. Finder compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
How likely would you be to recommend Finder to a friend or colleague?
0
1
2
3
4
5
6
7
8
9
10
Very UnlikelyExtremely Likely
Required
Thank you for your feedback.
Our goal is to create the best possible product, and your thoughts, ideas and suggestions play a major role in helping us identify opportunities to improve.
